J&J Theory On Blockbusters: They Are Built, Not Born
Executive Summary
Pharmaceutical blockbusters are more likely to emerge from an R&D program that downplays commercial forecasts, Johnson & Johnson Worldwide Pharmaceuticals Group Chairman Christine Poon suggested